Valuation: Highnoon Laboratories Limited

Market Cap 4.88TCr 18Cr 16Cr 15Cr 13Cr 25Cr 1.67TCr 25Cr 174.98Cr 69Cr 875.37Cr 66Cr 65Cr 2.77TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 4.88TCr 18Cr 16Cr 15Cr 13Cr 25Cr 1.67TCr 25Cr 174.98Cr 69Cr 875.37Cr 66Cr 65Cr 2.77TCr EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.43x
Free-Float
50.02%
Yield 2026 *
4.88%
Yield 2027 * 5.64%
1 day-1.04%
1 week+0.28%
Current month-1.26%
1 month-1.84%
3 months-6.80%
6 months-11.05%
Current year-9.90%
1 week 915.63
Extreme 915.63
980
1 month 910
Extreme 910
980
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 412
Extreme 412
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+0.28%-19.82%+121.86% 18Cr
+3.13%+4.80%+61.45%+127.47% 1,13300Cr
+4.19%+6.28%+39.52%+77.81% 62TCr
-0.11%+0.44%+24.47%+96.67% 50TCr
+0.03%+3.27%+39.79%+65.06% 38TCr
-1.08%+2.13%+69.25%+43.47% 37TCr
+1.58%+2.37%+22.91%+52.52% 29TCr
+2.90%+2.22%+3.51%+28.51% 26TCr
+2.32%+3.44%+51.68%+64.41% 24TCr
+2.16%-0.27%+29.21%+102.35% 19TCr
Average +1.33%+2.78%+32.20%+78.01% 39.88TCr
Weighted average by Cap. +1.91%+3.73%+43.28%+85.18%

Financials

2026 *2027 *
Net sales 3.04TCr 11Cr 9.8Cr 9.05Cr 8.22Cr 15Cr 1.04TCr 16Cr 108.97Cr 43Cr 545.14Cr 41Cr 40Cr 1.73TCr 3.42TCr 12Cr 11Cr 10Cr 9.24Cr 17Cr 1.17TCr 18Cr 122.47Cr 48Cr 612.66Cr 46Cr 45Cr 1.94TCr
Net income - -
Net Debt - -
Projected Income Statement - Annual - Highnoon Laboratories Limited
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
22/26/22 PKR 921.27 -1.04% 1,799
21/26/21 PKR 930.91 -0.70% 6,252
20/26/20 PKR 937.43 -0.09% 25,037
19/26/19 PKR 938.27 +0.68% 14,495
16/26/16 PKR 931.97 +1.71% 4,414
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
921.27PKR
Average target price
1,121.00PKR
Spread / Average Target
+21.68%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Highnoon Laboratories Limited
  1. Stock Market
  2. Stocks
  3. HINOON Stock